手術用プレジェットの英国市場：2025年～2033年

英国の手術用プレジェット市場は、2024年に1,350万米ドルに達し、2033年までには2,090万米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは5.4%で成長すると予測されています。

手術用プレジェットは、縫合の効果を高めるために外科手術で使用される特殊な医療機器です。主にポリテトラフルオロエチレン（PTFE）製の非吸収性合成パッチです。これらのパッチは通常、小さく、平らで、弾力性があり、外科的介入中に縫合糸の下に配置するように設計されています。

手術用プレジェットの主な目的は、縫合糸を支えることです。縫合糸がデリケートな組織に適用される場合、縫合糸が作用する張力によって周囲の組織が裂けたり損傷したりする危険性があります。プレジェットは、縫合糸の張力を広い範囲に分散させることで、このリスクを軽減します。このように広範囲に分散させることで、組織への局所的な圧迫を軽減し、ひずみや傷害の可能性から組織を保護することができます。このような要因が、英国の手術用プレジェット市場拡大の原動力となっています。

市場力学：

促進要因と抑制要因

手術技術の進歩

手術技術の進歩は、手術用プレジェットの英国市場の成長促進要因であり、その有効性、安全性、応用性を大幅に高めています。材料科学における最近の動向は、ポリテトラフルオロエチレン（PTFE）やその他の生体適合性ポリマーなど、外科用小道具のための高度な合成材料の開発につながりました。これらの材料は、組織反応性が低く、耐久性が高いため、外科用途に理想的です。

現代の手術環境は、ロボット支援手術や強化画像システムなどの技術をますます取り入れるようになっています。手術用プレジェットは、これらのシステムとシームレスに統合できるように設計されており、より正確な配置と治療成績の向上を可能にしています。このような技術統合は、外科手術の全体的な有効性を高めます。これらすべての要因が、英国の手術用プレジェット市場に需要をもたらしています。さらに、低侵襲手術に対する需要の高まりも、英国の手術用プレジェット市場の拡大に寄与しています。

手術用プレジェットの高コスト

手術用プレジェットのコストが高いことは、英国の手術用プレジェット市場における大きな抑制要因であり、ヘルスケアプロバイダーと患者の両方に影響を与えています。特に限られた予算で運営されている病院や手術センターにとっては、手術用プレジェットの高価格が財政的な課題となっています。高額なコストに直面すると、これらの施設はプレジェットのような特殊な物品よりも必要不可欠な医療用品を優先する可能性があり、手術中の利用可能性に影響を及ぼす可能性があります。

コストの上昇は、必要な外科手術への患者のアクセスを制限する可能性があります。ヘルスケア施設がこれらの費用を吸収できない場合、患者にその費用を転嫁し、手術費用を低く抑える可能性があります。このような経済的障壁は、患者が時宜を得た外科的介入を求めることを躊躇させ、治療の遅れや健康状態の悪化につながる可能性があります。

手術用プレジェットが高額であるため、医療提供者は、より費用対効果が高いと思われる手術用ステープラーや粘着ストリップなどの創傷閉鎖方法を検討する可能性があります。このような選好の変化は、医療提供者が予算の制約に合った代替手段を選ぶため、手術用プレジェット市場の成長を妨げる可能性があります。したがって、上記の要因は、英国の手術用プレジェット市場の潜在的な成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 外科技術の進歩
  • 抑制要因
    • 手術用プレジェットの高額な費用
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 タイプ別

• 非吸収性ガーゼ
• 吸収性ガーゼ

第7章 材料別

• ポリテトラフルオロエチレン（PTFE）
• ポリプロピレン
• ダクロン
• その他

第8章 用途別

• 心臓手術
• 胸部外科
• 一般外科
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター（ASC）
• その他

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Medtronic
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 過去および予測の製品販売
    • 製品販売量
  • 財務概要
    • 会社の収益
    • 地域別収益分配
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• B. Braun SE
• Johnson & Johnson（Ethicon）
• Teleflex Incorporated.
• PetersSurgical
• DeRoyal Industries, Inc.
• BD
• Boz Medical
• Advanced MedTech Solutions Pvt. Ltd
• Golnit

第12章 付録

The U.K. surgical pledgets market reached US$ 13.50 million in 2024 and is expected to reach US$ 20.90 million by 2033, growing at a CAGR of 5.4 % during the forecast period 2025-2033.

Surgical pledgets are specialized medical devices utilized in surgical procedures to improve the effectiveness of sutures. They are non-absorbable synthetic patches primarily constructed from polytetrafluoroethylene (PTFE). These patches are typically small, flat, and resilient and are designed to be placed beneath sutures during surgical interventions.

The main purpose of surgical pledgets is to serve as suture supports. When sutures are applied to delicate tissues, there is a risk that the tension exerted by the sutures may cause tearing or damage to the surrounding tissue. Pledgets help alleviate this risk by distributing the tension of the sutures over a wider area. This broader distribution reduces localized pressure on the tissue, thereby protecting it from strain and potential injury. These factors have driven the U.K. surgical pledgets market expansion.

Market Dynamics: Drivers & Restraints

Advancements in Surgical Technologies

Advancements in surgical technologies are a crucial driver of growth in the U.K. surgical pledgets market, significantly enhancing their effectiveness, safety, and application. Recent innovations in materials science have led to the development of advanced synthetic materials for surgical pledgets, such as polytetrafluoroethylene (PTFE) and other biocompatible polymers. These materials exhibit low tissue reactivity and high durability, making them ideal for surgical applications.

Modern surgical environments are increasingly incorporating technologies such as robotic-assisted surgery and enhanced imaging systems. Surgical pledgets are being designed to integrate seamlessly with these systems, allowing for more precise placement and improved outcomes. This technological integration enhances the overall efficacy of surgical procedures. All these factors demand the U.K. surgical pledgets market. Moreover, the growing demand for minimally invasive surgeries contributes to the U.K. surgical pledgets market expansion.

High Cost of Surgical Pledgets

The high cost of surgical pledgets is a significant constraint in the U.K. surgical pledgets market, impacting both healthcare providers and patients. The substantial price of surgical pledgets presents a financial challenge for hospitals and surgical centers, especially those operating with limited budgets. When confronted with high costs, these facilities may prioritize essential medical supplies over specialized items like pledgets, potentially affecting their availability during surgeries.

Elevated costs can restrict patient access to necessary surgical procedures. If healthcare facilities are unable to absorb these expenses, they may pass them on to patients, making surgeries less affordable. This financial barrier can deter patients from seeking timely surgical interventions, leading to delays in treatment and worsening health outcomes.

The high cost of surgical pledgets may lead healthcare providers to consider alternative wound closure methods, such as surgical staplers or adhesive strips, which are perceived as more cost-effective options. This shift in preference could hinder the growth of the surgical pledgets market as providers opt for alternatives that better fit their budget constraints. Thus, the above factors could be limiting the U.K. surgical pledgets market's potential growth.

Segment Analysis

The U.K. surgical pledgets market is segmented based on type, material, application, end-user, and region.

Type:

The non-absorbable pledgets segment is expected to dominate the U.K. surgical pledgets market share

The non-absorbable pledgets segment holds a major portion of the U.K. surgical pledgets market share and is expected to continue to hold a significant portion of the U.K. surgical pledgets market share during the forecast period.

Non-absorbable pledgets are synthetic devices specifically designed to provide reinforcement and support to sutured tissues during surgical procedures. They are primarily made from materials such as Polytetrafluoroethylene (PTFE) known for their exceptional durability, low friction, and minimal tissue reactivity, making them suitable for long-term applications. Polyester is valued for its strength and compatibility with various surgical techniques. These materials are selected for their ability to withstand biological environments without degrading, ensuring their effectiveness throughout the healing process.

Non-absorbable pledgets hold a significant share of the U.K. surgical pledgets market due to their widespread adoption across various surgical specialties. Their durability and low risk of complications contribute to their popularity among healthcare providers.

Non-absorbable pledgets are utilized in several key areas of cardiac surgery they provide essential support during procedures such as aortic valve replacements and coronary artery bypass grafts, where maintaining suture integrity is critical. Thoracic surgery is used to reinforce sutures in lung surgeries, ensuring stability and minimizing complications. General surgery is employed in diverse surgical procedures to enhance suture performance and reduce tissue damage.

The increasing prevalence of cardiovascular diseases among the aging population in the U.K. is driving demand for non-absorbable pledgets. As the geriatric demographic expands, so does the need for surgical interventions that utilize these devices. Innovations in material science are leading to the development of more effective non-absorbable pledget designs, enhancing their performance and broadening their applications across different surgical specialties. These factors have solidified the segment's position in the U.K. surgical pledgets market.

Competitive Landscape

The major players in the U.S. pollinosis market include Medtronic, B. Braun SE, Johnson & Johnson (Ethicon), Teleflex Incorporated., PetersSurgical, DeRoyal Industries, Inc., BD, Boz Medical, Advanced MedTech Solutions Pvt. Ltd, and Golnit among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The U.K. surgical pledgets market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Material
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Advancements in Surgical Technologies
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Surgical Pledgets
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Non-Absorbable Pledgets*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Absorbable Pledgets

7. By Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 7.1.2. Market Attractiveness Index, By Material
• 7.2. Polytetrafluoroethylene (PTFE)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Polypropylene
• 7.4. Dacron
• 7.5. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cardiac Surgery*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Thoracic Surgery
• 8.4. General Surgery
• 8.5. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers (ASCs)
• 9.5. Others

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. B. Braun SE
• 11.3. Johnson & Johnson (Ethicon)
• 11.4. Teleflex Incorporated.
• 11.5. PetersSurgical
• 11.6. DeRoyal Industries, Inc.
• 11.7. BD
• 11.8. Boz Medical
• 11.9. Advanced MedTech Solutions Pvt. Ltd
• 11.10. Golnit

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us